Develops antimicrobial catheter lock solutions for kidney failure patients.
Jun 2026Revenue $462M/yrExpenses $245M/yr
Reached break-even Feb 2025
Figures by year
When did CorMedix become profitable?
Its revenue passed its expenses in Feb 2025. In the 12 months to Jun 2026, revenue was $462M and expenses $245M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $312M | $162M | $150M |
| Dec 2024 | $43.5M | $65.8M | −$22.4M |
| Dec 2022 | $65.4K | $30.7M | −$30.6M |
| Dec 2021 | $191K | $29.6M | −$29.4M |
| Dec 2020 | $239K | $27.5M | −$27.2M |
| Dec 2019 | $283K | $21.3M | −$21.0M |
| Dec 2018 | $430K | $27.3M | −$26.9M |
| Dec 2017 | $329K | $33.3M | −$32.9M |
| Dec 2016 | $224K | $25.0M | −$24.8M |
| Dec 2015 | $210K | $16.9M | −$16.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.